Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss in Western India is common and often linked to metabolic syndrome.

Botulinum toxin A has limited effectiveness for 3 months in treating female pattern hair loss and may reduce scalp oiliness.

Many women with hair loss also have thyroid issues, high blood pressure, and low Vitamin D.

Women's hair grows faster and thicker than men's, but hair growth slows for both genders with pattern hair loss.

Certain genes may influence hair loss differently in men and women.

Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.

Hair transplantation is the only permanent solution for female pattern hair loss and can greatly improve quality of life with careful planning.

Many women with hair loss also have zinc deficiency, iron depletion, or thyroid issues.

Oxidative stress may worsen female pattern hair loss and could help track the disease and treatment.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

About 41% of Indian hair loss patients have low enzyme activity that affects hair loss treatment effectiveness, with men affected more than women. Testing for this can guide treatment.

Monofilament Threads significantly improve hair growth in women with pattern hair loss and are safe.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

The algorithm can effectively diagnose different types of female hair loss with proper history, examination, and tests.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Low iron and vitamin D levels are linked to hair loss in women.

Women's hair generally gets thinner and less dense starting in their mid-thirties, with hair loss becoming more common as they age due to both genetics and environment.

Hair transplants are effective for male and female pattern baldness, have evolved in technique, and require careful planning for natural results and managing complications.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

The BASP classification is effective for diagnosing pattern hair loss in Indian men and women.

Genetics and hormones cause hair loss; finasteride treats it safely.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

The document concludes that proper diagnosis and a combination of medical, hair-care, and surgical treatments are important for managing alopecia in black women.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.